NetworkNewsBreaks – VistaGen Therapeutics Inc. (
Post# of 130
(Total Views: 212)
Posted On: 07/07/2021 3:12:33 PM
NetworkNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Key Board Appointment of Mary L. Rotunno
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, today announced the appointment of Mary L. Rotunno, J.D. to its board of directors. “Mary brings to our team more than 30 years of leadership experience, which began with serving patients as a registered nurse and transitioned to serving clients in health care law, both allowing her to pursue her steadfast commitment to helping others and advancing the future of mental health and wellness,” said VistaGen CEO Shawn Singh. “Her extensive track record as an advocate for both patients and health care providers is unique and will provide deep and valuable insights into strategies for value-based care and an understanding of the entire life cycle of the mental health care experience. Mary has also served as a trusted advisor on complex governance, regulatory and compliance requirements for several companies. Her strategic vision, skill for scenario planning, and enterprise risk management expertise will be key in the next phases of our corporate development as we continue to pursue our core mission — to improve mental health and well-being for individuals in the U.S. and abroad.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, today announced the appointment of Mary L. Rotunno, J.D. to its board of directors. “Mary brings to our team more than 30 years of leadership experience, which began with serving patients as a registered nurse and transitioned to serving clients in health care law, both allowing her to pursue her steadfast commitment to helping others and advancing the future of mental health and wellness,” said VistaGen CEO Shawn Singh. “Her extensive track record as an advocate for both patients and health care providers is unique and will provide deep and valuable insights into strategies for value-based care and an understanding of the entire life cycle of the mental health care experience. Mary has also served as a trusted advisor on complex governance, regulatory and compliance requirements for several companies. Her strategic vision, skill for scenario planning, and enterprise risk management expertise will be key in the next phases of our corporate development as we continue to pursue our core mission — to improve mental health and well-being for individuals in the U.S. and abroad.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)